<DOC>
	<DOCNO>NCT00513552</DOCNO>
	<brief_summary>Crohn 's disease chronic inflammatory disorder gastrointestinal tract . The origin Crohn 's disease remain unknown curative therapy , either medical surgical , gut disorder . It believe infectious agent important development Crohn 's disease . The similarity Crohn 's disease animal form ileitis , term Johne 's disease , support possibility disorder cause exposure Mycobacterium avium paratuberculosis MAP . Multiple investigator demonstrate good clinical response patient Crohn 's disease treatment triple antibiotic therapy direct mycobacterial infection . The hypothesis protocol triple antibiotic therapy useful medical therapy patient Crohn 's disease . The aim study examine response patient Crohn 's disease receiving therapy biological agent triple antibiotic therapy .</brief_summary>
	<brief_title>Treatment Crohn 's Disease With Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis</brief_title>
	<detailed_description>Clinical remission determine decline Crohns disease activity index &lt; 151 ; clinical improvement examine use inflammatory bowel disease ( IBD ) quality life questionnaire ; endoscopic improvement examine use Crohn 's disease endoscopic activity index . All individual must colonoscopy within 3 month enrollment . An estimated 20 individual enrol protocol . Each patient treat 6 month combination rifabutin , clarithromycin , clofazimine . At end 6 month treatment patient , Crohns disease activity index recalculate , patient complete IBD quality life questionnaire , patient undergo repeat colonoscopy .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Paratuberculosis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<mesh_term>Clofazimine</mesh_term>
	<criteria>This study include patient capable provide informed consent , age 18 older . Patients must document diagnosis Crohn 's disease colonoscopy photograph within 3 month prior randomization . All patient must CDAI 220 great enrollment . All female must postmenopausal , surgically sterilize , either abstain sexual intercourse use nonhormonal method birth control addition oral contraceptive study 6 week end study . Any patient ulcerative colitis All woman childbearing age must negative urine pregnancy test within 1 week prior initial clinic visit . Patients receive biological therapy Crohn 's disease include remicade Patients know allergy three antibiotic use protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>